HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barré syndrome

CMAJ. Canadian Medical Association Journal

Volumn 166, Issue 8, 2002, Pages 1067-

  Wooltorton, Eric ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CREATINE KINASE; DNA POLYMERASE; LACTIC ACID; NUCLEOSIDE ANALOG; RIBOFLAVIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE;

ABDOMINAL PAIN; AMINOTRANSFERASE BLOOD LEVEL; ANION GAP; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG EXPOSURE; ENZYME INHIBITION; FATTY LIVER; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLACTATEMIA; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIPOATROPHY; LIVER DYSFUNCTION; LIVER FAILURE; LONG TERM EXPOSURE; MITOCHONDRION; MUSCLE ATROPHY; MUSCLE FATIGUE; MUSCLE WEAKNESS; MYALGIA; NAUSEA; NEUROMUSCULAR DISEASE; OBESITY; PANCREATITIS; PATIENT MONITORING; PERIPHERAL NEUROPATHY; PREGNANCY; RESPIRATORY FAILURE; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY; SYMPTOM; VOMITING; WEIGHT REDUCTION;

EID: 0036223752     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (8)

1. Recently identified adverse events secondary to NRTI therapy in HIV-infected individuals: Cases from the FDA's adverse event reporting system
2. Symptomatic lactic acidosis in hospitalized antiretroviral-treated patients with human immunodeficiency virus infection: A report of 12 cases
3. Hyperlactatemia and antiretroviral therapy: The Swiss HIV cohort study
4. Symptomatic hyperlactataemia: An emerging complication of antiretroviral therapy
5. Management of hyperlactatemia: No need for routine lactate measurements
6. Chronic hyperlactatemia in HIV-infected patients taking anti-retroviral therapy